TG Therapeutics, Inc. (TGTX)
56.05
+1.78
(+3.28%)
USD |
NASDAQ |
Aug 24, 16:00
56.45
+0.40
(+0.71%)
After-Hours: 19:58
TG Therapeutics 1 Year Total Returns (Daily) : 88.63% for Aug. 21, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 21, 2026 | 88.63% |
| August 20, 2026 | 78.59% |
| August 19, 2026 | 85.14% |
| August 18, 2026 | 81.25% |
| August 17, 2026 | 75.50% |
| August 14, 2026 | 75.51% |
| August 13, 2026 | 72.01% |
| August 12, 2026 | 82.52% |
| August 11, 2026 | 89.09% |
| August 10, 2026 | 84.05% |
| August 07, 2026 | 78.42% |
| August 06, 2026 | 78.88% |
| August 05, 2026 | 75.63% |
| August 04, 2026 | 69.69% |
| August 03, 2026 | 31.84% |
| July 31, 2026 | 46.56% |
| July 30, 2026 | 47.59% |
| July 29, 2026 | 51.37% |
| July 28, 2026 | 52.46% |
| July 27, 2026 | 51.08% |
| July 24, 2026 | 53.41% |
| July 23, 2026 | 47.61% |
| July 22, 2026 | 40.97% |
| July 21, 2026 | 44.17% |
| July 20, 2026 | 42.34% |
| Date | Value |
|---|---|
| July 17, 2026 | 40.01% |
| July 16, 2026 | 41.43% |
| July 15, 2026 | 48.60% |
| July 14, 2026 | 41.03% |
| July 13, 2026 | 48.33% |
| July 10, 2026 | 51.63% |
| July 09, 2026 | 55.75% |
| July 08, 2026 | 60.71% |
| July 07, 2026 | 61.37% |
| July 06, 2026 | 51.06% |
| July 02, 2026 | 46.90% |
| July 01, 2026 | 51.19% |
| June 30, 2026 | 52.65% |
| June 29, 2026 | 51.74% |
| June 26, 2026 | 47.11% |
| June 25, 2026 | 43.93% |
| June 24, 2026 | 43.70% |
| June 23, 2026 | 47.54% |
| June 22, 2026 | 51.03% |
| June 18, 2026 | 51.34% |
| June 17, 2026 | 47.14% |
| June 16, 2026 | 41.85% |
| June 15, 2026 | 39.68% |
| June 12, 2026 | 32.51% |
| June 11, 2026 | 25.39% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Krystal Biotech, Inc. | 137.9% |
| MAIA Biotechnology, Inc. | -9.15% |
| Vericel Corp. | 20.43% |
| Incyte Corp. | 47.71% |
| Regeneron Pharmaceuticals, Inc. | 40.13% |